[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@avidresearch Avatar @avidresearch avidresearch

avidresearch posts on X about $ovid, $mrna, $iobt, $idya the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks XXXX% finance XXXX%

Social topic influence $ovid #13, $mrna #18, $iobt #2, $idya #11, $oklo #87, $pfe 0.45%, $stok 0.45%, proof of 0.45%, prize 0.45%, q1 XXXX%

Top accounts mentioned or mentioned by @houndcl @plainyogurt21 @jfais20 @jeromeleonard5 @amaymd @267capital @nociftw @epickram @sharkbiotech @jacobplieth @scorpionfund @oncinvestor @banana_oncology @pickingmyown @biohazard3737 @mikeconvente @financebully @notgenentech @aaronrosenblum5 @learnbiotech

Top assets mentioned Moderna Inc (MRNA) IDEAYA Biosciences, Inc. Common Stock (IDYA) Oklo Inc. (OKLO) Pfizer, Inc. (PFE) Mineralys Therapeutics, Inc. Common Stock (MLYS) Cytokinetics Inc. (CYTK) Novo-Nordisk (NVO) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) uniQure N.V. (QURE) Rigetti Computing, Inc. Common Stock (RGTI)

Top Social Posts #

Top posts by engagements in the last XX hours

"@jfais20 Interesting alternative take. At end of the day Vigabatrin is very effective for patients with refractory seizures who haven't responded to other treatments. $OVID Management thesis that OV329 could be a more efficacious and safer alternative is very much intact"
X Link @avidresearch 2025-10-05T21:44Z 11.3K followers, 1482 engagements

"Dont understand $PFE price action. How does the deal reached yesterday have any impact on the pipeline (true valuation)"
X Link @avidresearch 2025-10-01T13:25Z 11.3K followers, 5945 engagements

"Fair to say $MRNA inferior to $IOBT (based on pd1 -ve data)"
X Link @avidresearch 2025-10-13T12:12Z 11.3K followers, 7082 engagements

"@Biohazard3737 $IDYA mUM ph3 data"
X Link @avidresearch 2025-09-29T17:35Z 11.3K followers, 1594 engagements

"Acting like a buyout candidate"
X Link @avidresearch 2025-10-14T20:22Z 11.3K followers, 3692 engagements

"$OVID X potentially good drugs"
X Link @avidresearch 2025-10-03T15:49Z 11.3K followers, 4811 engagements

"$MLYS $CYTK $NKTR $ABVX attractive M&A candidates"
X Link @avidresearch 2025-09-17T17:24Z 11.3K followers, 7034 engagements

"$OKLO barely any revenues. If we use biotech valuation methods this would trade at $1"
X Link @avidresearch 2025-10-15T13:33Z 11.3K followers, 1532 engagements

"$mrna copying $IOBT MOA. Good data"
X Link @avidresearch 2025-10-12T22:10Z 11.3K followers, 7657 engagements

"@semodough Think $NVO is FINALLY diversifying out of obesity"
X Link @avidresearch 2025-10-15T12:58Z 11.3K followers, XXX engagements

"$IDYA its easy to get lost in the flurry of data updates but this combo with Trodelvy in urothelial cancer is actually quite good"
X Link @avidresearch 2025-09-08T13:13Z 11.3K followers, 5638 engagements

"@JoseRestonVA @HeikwanTrades $OVID data release was a lot better than many realized. Biomarker data confirms there is high probability of efficacy translating (exceeding 1st gen drug) plus safety which was incredibly benign"
X Link @avidresearch 2025-10-05T11:38Z 11.3K followers, XXX engagements

"$BHVN might pull a $QURE if it gets troriluzole gets approved. 3-yr data vs external controls"
X Link @avidresearch 2025-09-24T17:15Z 11.3K followers, 38.2K engagements

"@DeepSouthDoctor At some point all the mindless bids pumping these have to run out of steam. $RGTI $OKLO"
X Link @avidresearch 2025-10-15T13:48Z 11.3K followers, XXX engagements